ENTRY       D12517                      Drug
NAME        Vobramitamab (USAN/INN)
FORMULA     C6400H9878N1714O2006S46
EXACT_MASS  144313.0785
MOL_WEIGHT  144402.1815
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVKPGGSLRL SCAASGFTFS SYGMSWVRQA PGKGLEWVAT INSGGSNTYY
            PDSLKGRFTI SRDNAKNSLY LQMNSLRAED TAVYYCARHD GGAMDYWGQG TTVTVSSAST
            KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKRVEPKSC DKTHTCPPCP APELLGGPSV
            FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSREEMTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG
            NVFSCSVMHE ALHNHYTQKS LSLSPG
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRASESIY SYLAWYQQKP GKAPKLLVYN TKTLPEGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQH HYGTPPWTFG QGTRLEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H96, H144-H200, H220-L215, H226-H'226, H229-H'229, H261-H321, H367-H425, H'22-H'96, H'144-H'200, H'220-L'215, H'261-H'321, H'367-H'425, L23-L88, L135-L195, L'23-L'88, L'135-L'195)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody
TARGET      CD276 [HSA:80381] [KO:K06746]
  PATHWAY   hsa04514(80381)  Cell adhesion molecules
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD276
                 D12517  Vobramitamab (USAN/INN)
DBLINKS     CAS: 2490556-50-6
///
